内核辐射通过升级caspase8和激活亡来抑制固体瘤的生长
Chenxu Shao1, Xiaoping Yan2, Hui Li3
1Department of Nuclear Medicine, School of Laboratory Medicine, Bengbu Medical University, Bengbu 233030, Anhui Province, P. R. China.
Molecular pharmaceutics
|July 30, 2024
概括
使用-131标记的atezolizumab的放射性免疫疗法通过上调Caspase8和NLRP3来增强抗癌效应,改善了瘤携带小鼠的存活率.
科学领域:
- 在瘤学瘤学.
- 放射性药物疗法是一种放射性药物疗法.
- 免疫治疗是一种免疫疗法.
背景情况:
- 放射性免疫疗法 (RIT) 是一种有前途的癌症治疗方法.
- 了解RIT对瘤生物学的影响对于改善结果至关重要.
- 需要对RIT抗体选择,放射性核素和患者群体进行进一步的研究.
研究的目的:
- 在临床前癌症模型中研究使用标记为atezolizumab (131I-atezolizumab) 的-131放射性免疫疗法的疗效.
- 探索I-atezolizumab抗瘤作用背后的分子机制.
- 评估放射性药物和免疫治疗的组合,以增强抗瘤效果.
主要方法:
- 我对抗PD-L1单克隆抗体阿特佐利祖马布的标签.
- 放射性标记抗体的净化和稳定性测试.
- 在体内生物分布研究和SPECT成像.
- 在I-atezolizumab治疗后,对携带瘤的小鼠生存率的评估.
- 通过Western blot,qPCR,免疫组织化学和TUNEL染色来分析Caspase8,NLRP3表达和亡.
主要成果:
- 131I-atezolizumab表现出高稳定性和体内生物活性.
- 治疗显著改善了瘤携带小鼠的存活率.
- 我内部辐射调节了Caspase8,激活了亡并抑制了瘤的生长.
- 观察到NLRP3的表达增加,这表明烧途径的参与.
- 与单一疗法相比,联合放射性药物和免疫疗法显示出更好的抗瘤效果.
结论:
- [131]I-atezolizumab是一种稳定且生物活性放射性药物,具有显著的抗瘤功效.
- 组合疗法通过调节亡和亡途径,有效抑制瘤生长.
- 这种方法为改善患者预后和开发癌症治疗中的新组合治疗策略提供了新的见解.
相关概念视频
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Cells of the Innate Immune Response
1.6K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498


